Publications by authors named "E Algin"

Claim this Profile
B
Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab.
Erdem Ozkan, Murathan Koksal, Bunyamin Ece, Mustafa Koyun, Omer Faruk Kuzu, Efnan Algin

Radiol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival advantage of bevacizumab rechallenge in recurrent ovarian cancer regardless of platinum sensitivity.
Ugur Ozberk, Selin Akturk Esen, Serhat Sekmek, Ismet Seven, Oznur Bal, Efnan Algin

Anticancer Drugs· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elderly Men with De Novo Metastatic Castration-Sensitive Prostate Cancer: Therapy and Does Comorbidity Matter.
Ugur Ozberk, Selin Akturk Esen, Alican Uguz, Efnan Algın, Oznur Bal

Medicina (Kaunas)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Efficacy of First-Line Pemetrexed-Platinum and Gemcitabine-Platinum Regimens in Malignant Peritoneal Mesothelioma.
Doğan Bayram, Safa Can Efil, Serap Türk, Oğuz Kara, Serhat Sekmek, Efnan Algin

Clin Med Insights Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic Disease Characteristics and Their Association with Adjuvant Chemotherapy Outcomes in Pulmonary Large-Cell Carcinoma Patients with or Without Neuroendocrine Features.
Doğan Bayram, Oznur Bal, Efe Cem Erdat, Serhat Sekmek, Saliha Yılmaz, Efnan Algin

Diagnostics (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis